Drug General Information (ID: DDIJ03T92F)
  Drug Name Dasatinib Drug Info Dexlansoprazole Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antineoplastics Proton Pump Inhibitors
  Structure

 Mechanism of Dasatinib-Dexlansoprazole Interaction (Severity Level: Major)
     Altered gastric pH Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Dasatinib Dexlansoprazole
      Mechanism Gastric pH sensitive Gastric alkalinizer
      Key Mechanism Factor 1
Factor Name Gastric pH
Factor Description The normal pH range of gastric acid is between 1.5 and 3.5 and is highly acidic, consisting mainly of hydrochloric acid. Changes in the pH of the stomach can alter the absorption of drugs.
      Mechanism Description
  • Decreased absorption of Dasatinib due to altered gastric pH caused by Dexlansoprazole 

Recommended Action
      Management Concomitant use of dasatinib with H2-receptor antagonists or proton pump inhibitors is not recommended. If gastric acidity management is necessary, antacids should be considered in place of these agents. However, patients treated with dasatinib should avoid taking antacids or oral medications that contain antacids (e.g., didanosine buffered tablets or pediatric oral solution) for at least two hours before and two hours after administration of dasatinib.

References
1 Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.